Opulent Conferences | Medical Events | Scientific Meetings | USA

<!doctype html> <html class="no-js" lang="en"> <head>  <meta charset="utf-8"> <meta http-equiv="X-UA-Compatible" content="IE=edge"> <meta name="viewport" content="width=device-width, initial-scale=1">  <meta name="csrf-token" content="ttnFuIT27vkacgFLOcAFnR8RUQobarb5xVXwBIAQ"> <meta name="title" content="Opulent Conferences | Events | Meetings | USA | Europe"> <meta name="keywords" content="international conferences, top europe conferences, asia pacific medical Events, opulent medical conferences, life science scientific events"> <meta name="description" content="Join Opulent conferences for professionals and students in medicine, life sciences, engineering, and business. Network in the USA, Europe, Asia, and the Middle East."> <meta name="image" content="settings/March2024/R5h48THhdK41LV5svQYv.png"> <meta name="url" content="https://opulentconferences.com" > <meta name="author" content="Opulent Conferences">  <link rel="preload" href="https://fonts.gstatic.com/s/poppins/v15/Yq6W-LyURyLyfA.woff2" as="font" type="font/woff2" crossorigin="anonymous"> <link rel="preload" href="https://fonts.gstatic.com/s/poppins/v21/pxiByp8kv8JHgFVrLEj6Z1xlFQ.woff2" as="font" type="font/woff2" crossorigin="anonymous"> <link rel="preload" href="https://fonts.gstatic.com/s/poppins/v21/pxiByp8kv8JHgFVrLEj6Z1xlFQ.woff2" as="font" type="font/woff2" crossorigin="anonymous"> <link rel="preload" href="https://fonts.gstatic.com/s/poppins/v21/pxiByp8kv8JHgFVrLEj6Z1xlFQ.woff2" as="font" type="font/woff2" crossorigin="anonymous"> <link rel="preload" href="https://fonts.gstatic.com/s/poppins/v21/pxiEyp8kv8JHgFVrLEj6Z1xlFQ.woff2" as="font" type="font/woff2" crossorigin="anonymous">  <link rel="preload" href="https://opulentconferences.com/public/front_assets/css/font-awesome.min.css" as="style" onload="this.onload=null;this.rel='stylesheet'"> <noscript><link rel="stylesheet" href="https://opulentconferences.com/public/front_assets/css/font-awesome.min.css"></noscript> <link rel="preload" href="https://opulentconferences.com/public/front_assets/css/linearicons.css" as="style" onload="this.onload=null;this.rel='stylesheet'"> <noscript><link rel="stylesheet" href="https://opulentconferences.com/public/front_assets/css/linearicons.css"></noscript> <link rel="preload" href="https://opulentconferences.com/public/front_assets/css/flaticon.css" as="style" onload="this.onload=null;this.rel='stylesheet'"> <noscript><link rel="stylesheet" href="https://opulentconferences.com/public/front_assets/css/flaticon.css"></noscript> <link rel="preload" href="https://opulentconferences.com/public/front_assets/css/animate.css" as="style" onload="this.onload=null;this.rel='stylesheet'"> <noscript><link rel="stylesheet" href="https://opulentconferences.com/public/front_assets/css/animate.css"></noscript> <link rel="preload" href="https://opulentconferences.com/public/front_assets/css/owl.carousel.min.css" as="style" onload="this.onload=null;this.rel='stylesheet'"> <noscript><link rel="stylesheet" href="https://opulentconferences.com/public/front_assets/css/owl.carousel.min.css"></noscript> <link rel="preload" href="https://opulentconferences.com/public/front_assets/css/owl.theme.default.min.css" as="style" onload="this.onload=null;this.rel='stylesheet'"> <noscript><link rel="stylesheet" href="https://opulentconferences.com/public/front_assets/css/owl.theme.default.min.css"></noscript> <link rel="preload" href="https://opulentconferences.com/public/front_assets/css/bootstrap.min.css" as="style" onload="this.onload=null;this.rel='stylesheet'"> <noscript><link rel="stylesheet" href="https://opulentconferences.com/public/front_assets/css/bootstrap.min.css"></noscript> <link rel="preload" href="https://opulentconferences.com/public/front_assets/css/bootsnav.css" as="style" onload="this.onload=null;this.rel='stylesheet'"> <noscript><link rel="stylesheet" href="https://opulentconferences.com/public/front_assets/css/bootsnav.css"></noscript> <link rel="preload" href="https://opulentconferences.com/public/front_assets/css/style.css" as="style" onload="this.onload=null;this.rel='stylesheet'"> <noscript><link rel="stylesheet" href="https://opulentconferences.com/public/front_assets/css/style.css"></noscript> <link rel="preload" href="https://opulentconferences.com/public/front_assets/css/responsive.css" as="style" onload="this.onload=null;this.rel='stylesheet'"> <noscript><link rel="stylesheet" href="https://opulentconferences.com/public/front_assets/css/responsive.css"></noscript> <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.1.1/css/all.min.css"> <style> /* Ensure font-display swap for all web fonts */ @font-face { font-family: 'Poppins'; src: url('https://fonts.gstatic.com/s/poppins/v21/pxiByp8kv8JHgFVrLEj6Z1xlFQ.woff2') format('woff2'); font-display: swap; } /* Reserve space for elements */ #clients-say { background: #f8f9fb; position: relative; top: -154px; min-height: 300px; width: 100%; / } .nav.navbar-nav.navbar-right { min-width: 200px; } .dropdown:hover .dropdown-menu { display: block; margin-top: 0; /* Remove any margin that might hide the menu */ } nav.navbar.bootsnav li.dropdown ul.dropdown-menu > li { display: block; text-align: left !important; } </style>  <link href="https://fonts.googleapis.com/css?family=Poppins:100,100i,200,200i,300,300i,400,400i,500,500i,600,600i,700,700i,800,800i,900,900i" rel="stylesheet"> <link href="https://fonts.googleapis.com/css?family=Rufina:400,700&display=swap" rel="stylesheet">  <title>Opulent Conferences | Medical Events | Scientific Meetings | USA | Europe</title>  <link rel="apple-touch-icon" sizes="180x180" href="https://opulentconferences.com/public/front_assets/images/fav-icon/apple-touch-icon.png"> <link rel="icon" type="image/png" sizes="32x32" href="https://opulentconferences.com/public/front_assets/images/fav-icon/favicon-32x32.png"> <link rel="icon" type="image/png" sizes="16x16" href="https://opulentconferences.com/public/front_assets/images/fav-icon/favicon-16x16.png"> <link rel="manifest" href="https://opulentconferences.com/public/front_assets/images/fav-icon/site.webmanifest">  <link rel="manifest" href="/public/manifest.json"> </head>  <script async src="https://www.googletagmanager.com/gtag/js?id=G-1SDV84F0MY"></script> <script> window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-1SDV84F0MY'); </script> <body>  <section id="home" class="welcome-hero">  <div class="top-area"> <div class="header-area">  <nav class="navbar navbar-default bootsnav navbar-sticky navbar-scrollspy" data-minus-value-desktop="70" data-minus-value-mobile="55" data-speed="1000"> <div class="container-fluid">  <div class="navbar-header"> <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#navbar-menu" aria-label="Toggle navigation"> <i class="fa fa-bars"></i> </button> <a class="navbar-brand" href="https://opulentconferences.com" aria-label="Opulent Conferences Home"> <img src="https://opulentconferences.com/public/front_assets/images/event/header-logo.png" alt="Opulent Conferences Home" width="200" height="50"/> </a> </div>   <div class="collapse navbar-collapse menu-ui-design" id="navbar-menu"> <ul class="nav navbar-nav navbar-right" data-in="fadeInDown" data-out="fadeOutUp"> <li class=""><a href="/"><i class="fas fa-map-location"></i>Home</a></li> <li class=""><a href="https://opulentconferences.com/about-us" aria-label="About Us">About Us</a></li> <li class="dropdown" id="dropdownMenuButton"> <a href="#" class="dropdown-toggle" data-toggle="dropdown" aria-label="Open Events Dropdown"> <i class="fas fa-grip-vertical"></i> Events </a> <ul class="dropdown-menu"> <li class="dropdown-item"><a href="https://opulentconferences.com/all-event" aria-label="Upcoming Events"><i class="fas fa-map-location"></i>Upcoming Events</a></li> <li class="dropdown-item"><a href="https://opulentconferences.com/venue" aria-label="Venues"><i class="fas fa-map-location"></i>Venues</a></li> <li class="dropdown-item"><a href="https://opulentconferences.com/events/view-more" aria-label="Categories"><i class="fas fa-bars-staggered"></i>Categories</a></li> </ul> </li> <li class=""><a href="https://opulentconferences.com/sponsor" aria-label="Sponsor">Sponsor</a></li> <li class="dropdown" id="dropdownMenuButton"> <a href="#" class="dropdown-toggle" data-toggle="dropdown"> <i class="fas fa-grip-vertical"></i> More </a> <ul class="dropdown-menu"> <li><a class="dropdown-item" href="https://opulentconferences.com/registration-policies">Registration Policies</a></li> <li><a class="dropdown-item" href="https://opulentconferences.com/terms-and-conditions">Terms and Conditions</a></li> <li><a class="dropdown-item" href="https://opulentconferences.com/privacy-policies">Privacy Policies</a></li> <li><a class="dropdown-item" href="https://opulentconferences.com/cancellation-and-refund-policy">Cancellation and Refund Policy</a></li> <li><a class="dropdown-item" href="https://opulentconferences.com/feedback-complaints">Feedback & Complaints</a></li> <li><a class="dropdown-item" href="https://opulentconferences.com/contact-us">Contact Us</a></li> <li><a class="dropdown-item" href="https://opulentconferences.com/faqs">Faqs</a></li> </ul> </li> <li class=""><a href="https://opulentconferences.com/login" aria-label="Login"><i class="fas fa-fingerprint"></i>Login</a></li> <li class=""><a href="https://opulentconferences.com/register" aria-label="Register"><i class="fas fa-user-plus"></i>Register</a></li> <li ><a href="https://opulentconferences.com/abstract-submission" class="book-now-btn" aria-label="Abstract Submission">Abstract Submission</a></li> </ul> </div> </div> </nav>  </div> <div class="clearfix"></div> </div>  </section>  <div class="tap-top"> <a href="https://wa.me/+441633494617" aria-label="Chat with us on WhatsApp"> <i class="text-white fab fa-whatsapp"></i> </a> </div>  <section> <div class="bg-gradt" style="height: 78px;background-color:black;"> </div> </section> <section> <div class="owl-carousel owl-theme" id="new-cars-carousel"> <div class="new-cars-item"> <div class="single-new-cars-item"> <div class="row"> <div class="col-md-12 col-sm-12"> <div class="new-cars-img"> <img src="https://opulentconferences.com/public/banner/1048389-1721092216.jpeg" alt="" height="450px" width="100%"/> </div> </div> </div> </div> </div> </div> </section> <section class="tab-section"> <div class="container"> <div class="row"> <div class="col-md-8 tab-col"> <div class="tab"> <button class="tablinks active" onclick="openCity(event, 'short_note')">Welcome</button> <button class="tablinks" onclick="openCity(event, 'about')">About</button> <button class="tablinks" onclick="openCity(event, 'session')">Sessions & Tracks</button> <button class="tablinks" onclick="openCity(event, 'market')">Market Analysis</button>  <button class="tablinks" onclick="openCity(event, 'take_away')">Take Away</button> </div> <div id="short_note" class="tabcontent text-justify" style="display: block;"> <p style="text-align: center; "><span style="font-weight: 600;"><font color="#000000">Welcome to the World Congress on Gastrointestinal Research and Therapy 2025</font></span></p><p style="text-align: justify;"><font color="#000000">It is our great pleasure to invite you to the <span style="font-weight: 600;">World Congress on Gastrointestinal Research and Therapy 2025</span>, which will take place in the beautiful city of <span style="font-weight: 600;">Vienna, Austria</span> on <span style="font-weight: 600;">April 29-30, 2025</span>. This prestigious congress will serve as a global platform for researchers, scientists, clinicians, policymakers, industry experts, and healthcare professionals to exchange knowledge and discuss the latest advancements in gastrointestinal research and therapy.</font></p><p style="text-align: justify;"><font color="#000000">The congress will feature a diverse and dynamic program, designed to foster collaboration and inspire new ideas in the field of <span style="font-weight: 600;">gastroenterology</span>. With the theme <span style="font-weight: 600;">"Advancing Innovations in Gastrointestinal Research: From Bench to Bedside"</span>, we aim to address the challenges in gastrointestinal health, explore groundbreaking therapeutic developments, and share insights into emerging research across the world.</font></p><p style="text-align: center; "><b><font color="#000000">Keynote Sessions</font></b></p><p style="text-align: justify;"><font color="#000000">Our keynote sessions will bring together world-renowned experts to address the most pressing issues and breakthroughs in gastrointestinal research. Esteemed leaders in the field will deliver thought-provoking presentations on innovative diagnostic approaches, therapeutic strategies, and translational research that are shaping the future of gastrointestinal care. These sessions will serve as a foundation for meaningful discussions throughout the congress.</font></p><p style="text-align: center; "><b><font color="#000000">Plenary Speaker Presentations</font></b></p><p style="text-align: justify;"><font color="#000000">The plenary presentations will offer deep insights into specific gastrointestinal diseases, gut microbiome research, and novel therapeutic interventions. Our distinguished plenary speakers, chosen for their expertise and significant contributions to the field, will guide attendees through the most impactful research and its clinical implications, ensuring a comprehensive understanding of the current landscape.</font></p><p style="text-align: center; "><b><font color="#000000">Sessions and Scientific Tracks</font></b></p><p style="text-align: justify; "><font color="#000000">With a broad range of scientific tracks carefully curated for maximum impact, the congress will feature sessions led by expert session chairs. These sessions will explore critical areas including: Gut Microbiota, Innovative Endoscopic Techniques, Dietary Interventions, Genetic Insights, Microbial Dysbiosis, Gut-Brain Axis, Probiotics, Liver-Gut Connection, Gastrointestinal Oncology, Fecal Microbiota Transplantation, Systemic Diseases and GI Manifestations, Gut Permeability, Advances in GI Surgery, Esophageal Disorders, Environmental Impact, Biomarkers, Pharmacological Advances, Patient-Centered Care, Inflammatory Bowel Disease (IBD), Immunology in Gastrointestinal Diseases, Artificial Intelligence and Machine Learning in Gastroenterology, Pediatric Gastroenterology, GI Epidemiology and Public Health, Telemedicine and Digital Health in Gastroenterology.</font></p><p style="text-align: justify;"><font color="#000000">Each session will be an interactive space, designed to encourage participant engagement and foster collaborations that can lead to meaningful advances in gastrointestinal research.</font></p><p style="text-align: center;"><b><font color="#000000">Young Researchers Presentation</font></b></p><p style="text-align: justify;"><font color="#000000">We are committed to supporting the next generation of scientists and clinicians in the field. The Young Researchers Presentation provides a unique opportunity for emerging scholars to present their cutting-edge research to a global audience. This session will highlight innovative studies by young investigators and promote discussions that pave the way for future collaborations. We invite all attendees to engage with these young researchers and encourage their contributions to the field.</font></p><p style="text-align: center; "><b><font color="#000000">Poster Presentations and Exhibitions</font></b></p><p style="text-align: justify;"><font color="#000000">Throughout the congress, attendees will have the chance to explore a wide range of poster presentations, showcasing original research across all aspects of gastrointestinal science. These sessions will allow participants to engage directly with researchers, discuss methodologies, and explore innovative approaches to complex issues in a more personal and interactive setting.</font></p><p style="text-align: justify;"><font color="#000000">In addition, the congress will feature a variety of exhibitions from leading companies, showcasing the latest tools, technologies, and solutions in gastrointestinal research and clinical practice. Exhibitors will demonstrate innovations in diagnostic tools, therapeutic interventions, and medical devices that are transforming patient care and advancing the field of gastroenterology.</font></p><p class="MsoNormal" style="text-align: center;"><b><font color="#000000">Concluding Insights<o:p></o:p></font></b></p><p><font color="#000000">The World Congress on Gastrointestinal Research and Therapy 2025 promises to be an unparalleled opportunity for networking, learning, and collaboration. As we explore the evolving landscape of gastrointestinal research and clinical practice, we are confident that this congress will inspire new ideas, foster partnerships, and contribute to the advancement of gastrointestinal health worldwide.</font></p><p><font color="#000000">We look forward to welcoming you to Vienna, where you will experience two days of thought-provoking sessions, insightful discussions, and an opportunity to engage with leading minds in the field. Together, let us push the boundaries of science and therapy to improve patient care and outcomes globally.</font></p><p><font color="#000000">See you in Vienna!</font></p> </div> <div id="about" class="tabcontent text-justify"> <p class="MsoNormal"></p><div style="text-align: justify;"><p class="MsoNormal"><font color="#000000">Opulent Conferences is pleased to invite you to the <b>World Congress on Gastrointestinal Research and Therapy 2025</b>, taking place in <b>Vienna, Austria</b>, on <b>April 29–30, 2025</b>.<o:p></o:p></font></p><p class="MsoNormal"><font color="#000000">We kindly invite delegates, students, researchers, and notable academics to the Gastrointestinal Research and Therapy Conference. This is a great chance to participate in important scientific conversations and help shape the direction of future developments in the field of gastrointestinal research.<o:p></o:p></font></p><p class="MsoNormal"><font color="#000000">The Gastro 2025 conference will serve as a global forum for groundbreaking discoveries in all areas of gastrointestinal science. The topic for this year's Gastrointestinal Research Conference 2025 is "Challenges, Innovations and Advancements in Gastrointestinal Research and Therapy," with the intention of showcasing the forward-thinking advancements in research pertaining to disorders of the gastrointestinal tract.<o:p></o:p></font></p><p class="MsoNormal"><font color="#000000">The conference also acts as a top venue for networking and collaboration, giving you the chance to meet new people, share ideas, and create lasting relationships with important stakeholders, industry representatives, and other professionals in the field of gastrointestinal research. We highly recommend that you take advantage of this chance to grow your professional network. </font></p><p class="MsoNormal"><font color="#000000">We hope you will gain new perspectives, useful information, and priceless connections as you go through the conference schedule and participate in stimulating conversations that will advance the field of gastrointestinal health and improve your practice. Our common goal of advancing gastrointestinal research and therapy and enhancing patient outcomes globally depends heavily on your involvement and contributions.<o:p></o:p></font></p><p class="MsoNormal"> </p><p class="MsoNormal"><font color="#000000">Thank you for joining us on this journey of discovery and collaboration. We look forward to welcoming you to the Gastrointestinal Research conference and to the meaningful exchanges and experiences that lie ahead.</font><o:p></o:p></p></div> </div> <div id="session" class="tabcontent text-justify"> <p> </p><p class="MsoNormal" style="text-align: justify; line-height: normal; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;"><font color="#000000"><b><span style="font-family: Poppins;">Sessions and Tracks</span></b><span style="font-family: Poppins;"><o:p></o:p></span></font></p><p class="MsoNormal" style="text-align: justify; line-height: normal; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;"><font color="#000000"><span style="font-weight: 600;">Session 1: Gut Microbiota: </span>Gut Microbiota, which is made up of billions of microorganisms, is essential for immune system performance, illness prevention, and digestive health. IBS, obesity, and the metabolic syndrome are all associated with dysbiosis, or imbalances in the gut flora. The therapeutic potential of probiotics, prebiotics, and dietary treatments to repair healthy gut flora is the subject of recent research.<span style="line-height: 17.12px;"> </span></font></p><div style="text-align: justify;"><font color="#000000" style="">Prebiotics | Dysbiosis |  Commensal bacteria | Gut-brain axis | Short-chain fatty acids (SCFAs)    |   Antibiotics |  Fermentation |  Inflammation |  Metagenomics |  Bacteriophages  | Immune system  Host-microbe interactions  | Metabolomics | Biofilms | Fecal microbiota transplantation  | Pathobionts | Symbiosis | Microbial Diversity.</font></div><p></p><p class="MsoNormal" style="text-align: justify;"><font color="#000000"><b>Session 2: Innovative Endoscopic Techniques: </b>By increasing accuracy and reducing invasiveness, cutting-edge endoscopic procedures are transforming the diagnosis and management of gastrointestinal illnesses. The use of confocal laser endomicroscopy, high-definition endoscopy, and endoscopic ultrasonography (EUS) has made it possible to perform targeted biopsies and visualise intricate details. When eliminating early-stage tumours and polyps, mucosal resection (EMR) are a good substitute for traditional surgery.</font></p><p class="MsoNormal" style="text-align: justify;"><font color="#000000">Capsule endoscopy  | Endoscopic submucosal dissection (ESD) | Endoscopic mucosal resection (EMR) | Narrow-band imaging (NBI) |  Endoscopic ultrasound (EUS)  |  Confocal laser endomicroscopy (CLE) | Third space endoscopy  |  Endoscopic retrograde cholangiopancreatography (ERCP)  |  Peroral endoscopic myotomy (POEM) | Double-balloon enteroscopy  |  Single-balloon enteroscopy  |  Spy Glass system  |  Endoscopic sleeve gastroplasty (ESG)  |  Artificial intelligence (AI) in endoscopy  |  Virtual chromoendoscopy   |  Endoscopic full-thickness resection (EFTR)  |  Chromoendoscopy  |  Natural orifice transluminal endoscopic surgery  |  Barrett's esophagus ablation  |  Cryotherapy in endoscopy.</font></p><p class="MsoNormal" style="text-align: justify;"><b><font color="#000000"><br></font></b></p><p class="MsoNormal" style="text-align: justify;"><font color="#000000"><b>Session 3: Dietary Interventions: </b>Dietary interventions are essential in the management and prevention of gastrointestinal illnesses. By avoiding fermentable carbs, some diets, such the low-FODMAPS diet, are useful in easing the symptoms of irritable bowel syndrome (IBS). Anti-inflammatory diets high in antioxidants and omega-3 fatty acids are beneficial in the treatment of diseases including ulcerative colitis and Crohn's disease.</font></p><p class="MsoNormal" style="text-align: justify;"><font color="#000000">Nutritional therapy|  Caloric restriction  |  Intermittent fasting  |  Low-carbohydrate diet  |  Mediterranean diet  |  Plant-based diet  |  Ketogenic diet  |  Elimination diet  |  Gluten-free diet  |  Anti-inflammatory diet  |  Paleo diet  | Vegan diet |  Low-FODMAP diet |  DASH diet (Dietary Approaches to Stop Hypertension) |  Whole30 diet  |  Mindful eating  |  Portion control  | Glycemic index  |  Nutrient density |  Functional foods. </font></p><p class="MsoNormal" style="text-align: justify;"><b><font color="#000000"><br></font></b></p><p class="MsoNormal" style="text-align: justify;"><font color="#000000"><b>Session 4: Genetic Insights</b>: Genetic insights<span style="font-size:12.0pt;line-height:107%;font-family:"Times New Roman",serif; mso-fareast-font-family:"Times New Roman";mso-font-kerning:0pt;mso-ligatures: none;mso-fareast-language:EN-IN"> </span>components influencing gastrointestinal illnesses, including Crohn's disease, coeliac disease, and colorectal cancer, are becoming more clear thanks to genetic discoveries. Comprehending certain gene mutations and variants facilitates the identification of individuals who are susceptible, hence allowing for customised treatment plans and early intervention. Whole-genome sequencing and other genomic technology advancements are revealing the intricate relationships between genes and environmental variables that underlie GI disorders.</font></p><p class="MsoNormal" style="text-align: justify;"><font color="#000000">Genomics  | Genome sequencing  |  Epigenetics  |  CRISPR/Cas9  |  Gene expression  |  Single nucleotide polymorphisms (SNPs)  | Genetic variation  |  Heritability  |  Genetic mutations  |  Gene therapy  |  Transcriptomics  |  Mendelian inheritance  |  Genetic predisposition  |  Genetic markers  |  Gene-environment interaction  |  Pharmacogenomics  |  Polygenic risk scores  |Genetic engineering  |  Personalized medicine  | Genetic counselling.</font></p><p class="MsoNormal" style="text-align: justify;"><b><font color="#000000"><br></font></b></p><p class="MsoNormal" style="text-align: justify;"><b><font color="#000000"> </font></b></p><p class="MsoNormal" style="text-align: justify;"><font color="#000000"><b>S</b><b>ession 5: Microbial Dysbiosis: </b>A disruption in the gut microbiota known as microbial dysbiosis has been connected to a number of gastrointestinal conditions, including colorectal cancer, inflammatory bowel disease, and irritable bowel syndrome (IBS). Antibiotics, a bad diet, and stress are some of the things that might cause this imbalance in microbial diversity. Increased gut permeability, inflammation, and altered immunological responses are all possible consequences of dysbiosis.</font></p><p class="MsoNormal" style="text-align: justify;"><font color="#000000">Microbiome imbalance  |  Pathogenic overgrowth  |  Gut microbiota  |  Pro-inflammatory cytokines  |  Antibiotic resistance  |  Inflammatory bowel disease (IBD)  |  Irritable bowel syndrome (IBS)  |  Metabolic disorders  |  Autoimmune diseases  |  Chronic inflammation  |  Probiotics  | Prebiotics  |  Fecal microbiota transplantation (FMT)  |  Clostridioides difficile infection | Leaky gut syndrome  |  Small intestinal bacterial overgrowth (SIBO) | Microbial diversity loss  |  Host-microbe interactions  |  Immune modulation  | Dietary interventions.</font></p><p class="MsoNormal" style="text-align: justify;"><b><font color="#000000"><br></font></b></p><p class="MsoNormal" style="text-align: justify;"><font color="#000000"><b>Session 6: Gut-Brain Axis</b>-<span style="font-size: 12pt; line-height: 107%; font-family: "Times New Roman", serif;"> </span>The Gut-rain axis is a complex, two-way communication network that includes immunological, hormonal, and neurological pathways that connects the brain with the gastrointestinal tract. This relationship affects both digestive and mental health, with abnormalities associated with disorders like depression, anxiety, and irritable bowel syndrome (IBS). This relationship involves the gut microbiome, which influences immunological responses and neurotransmitter synthesis</font></p><p class="MsoNormal" style="text-align: justify; "><font color="#000000">Microbiota-gut-brain axis  |  Neurotransmitters  |  Serotonin |  Vagus nerve |  Microbial metabolites |  Short-chain fatty acids (SCFAs)  |  Brain-gut communication  |  Psychobiotics  |  HPA axis (Hypothalamic-pituitary-adrenal axis)  |  Inflammation  |  Blood-brain barrier  |  Neuroinflammation  |  Probiotics  |  Prebiotics  |  Stress response  |  Mental health  |  Anxiety  |  Depression  |  Cognitive function  |  Neurological disorders.</font></p><p class="MsoNormal" style="text-align: justify;"><b><font color="#000000"><br></font></b></p><p class="MsoNormal" style="text-align: justify;"><font color="#000000"><b>Session 7: Probiotics : </b>Probiotics,<b> </b>which are non-digestible fibres present in foods like whole grains and bananas, support healthy gut flora. When combined, they generate synbiotics, which balance the gut microbiota and improve immune system and digestive health. Combining the two can enhance immune system strength and digestion, which can benefit general wellbeing.</font></p><p class="MsoNormal" style="text-align: justify;"><font color="#000000">Lactobacillus |  Bifidobacterium |  Fermented foods |  Gut microbiota  |  Live microorganisms  |  Immune modulation  |  Gut health  |  Microbial balance  |  Dysbiosis |  Yogurt  |  Kefir  |  Prebiotics |  Synbiotics  |  Antibiotic-associated diarrhea  |  Inflammatory bowel disease (IBD)  | Irritable bowel syndrome (IBS)  |  Clostridioides difficile  |  Allergy prevention  |  Mental health  |   Nutrient absorption.</font></p><p class="MsoNormal" style="text-align: justify;"><b><font color="#000000"><br></font></b></p><p class="MsoNormal" style="text-align: justify;"><font color="#000000"><b>Session 8: Liver-Gut Connection</b>: Liver-gut connection underscores the interdependence between liver function and gastrointestinal health, facilitated by the portal vein linking the two systems. Liver diseases, such as non-alcoholic fatty liver disease (NAFLD) and cirrhosis, can impact gut microbiota composition and intestinal barrier integrity.<o:p></o:p></font></p><p class="MsoNormal" style="text-align: justify;"><font color="#000000">Gut-liver axis |  Microbiota   Portal vein  |  Bile acids  |   Hepatic metabolism  |  Liver inflammation  |  Non-alcoholic fatty liver disease (NAFLD)  |  Liver cirrhosis  |  Endotoxemia  |  Fibrosis | Cholestasis  |  Hepatocytes  |  Short-chain fatty acids (SCFAs) |  Gut permeability  |  Lipopolysaccharides (LPS) |  Hepatic steatosis  |  Immune response  |  Alcoholic liver disease (ALD)  |  Microbial translocation  |  Inflammatory mediators.</font></p><p class="MsoNormal" style="text-align: justify;"><b><font color="#000000"><br></font></b></p><p class="MsoNormal" style="text-align: justify;"><font color="#000000"><b>Session 9: Gastrointestinal Oncology:</b> Gastrointestina oncologies of the gastrointestinal tract, such as those affecting the oesophagus, stomach, liver, pancreas, intestines, and colon, are the focus of gastrointestinal oncology. It includes using surgery, chemotherapy, radiation therapy, and targeted therapies to diagnose, treat, and investigate tumours in these organs. For management to be effective, early detection is essential. This area of study also looks into environmental and genetic predispositions to cancer.<o:p></o:p></font></p><p class="MsoNormal" style="text-align: justify;"><font color="#000000">Colorectal Cancer |  Gastric Cancer |  Esophageal Cancer |  Pancreatic Cancer |  Liver Cancer |  Cholangiocarcinoma |  Gastrointestinal Stromal Tumors (GIST) | Hereditary Cancer Syndromes  | Lynch Syndrome |  Familial Adenomatous Polyposis (FAP)|  Endoscopic Ultrasound (EUS) |  Biomarkers |  Targeted Therapy |  Immunotherapy |  Chemotherapy |  Radiotherapy |  Surgical Oncology | Metastasis |  Precision Medicine |  Oncogenes.</font></p><p class="MsoNormal" style="text-align: justify;"><b><font color="#000000"><br></font></b></p><p class="MsoNormal" style="text-align: justify;"><font color="#000000"><b>Session 10: Fecal Microbiota Transplantation (FMT</b>): Fecal microbiota transplantation (FMT) involves transferring stool from a healthy donor to a recipient's gastrointestinal tract to restore healthy gut flora. It's primarily used to treat recurrent Clostridioides difficile infections and is being researched for other conditions like inflammatory bowel disease. FMT can be administered via colonoscopy, nasogastric tube, or capsules.<o:p></o:p></font></p><p class="MsoNormal" style="text-align: justify;"><font color="#000000">Gut Microbiota | Microbiome Restoration |  Clostridioides Difficile Infection | Dysbiosis |  Probiotics |  Antibiotic-Resistant Bacteria | Bacteriotherapy |  Donor Screening |  Recipient Preparation |  Colonoscopy |  Enema |  Nasogastric Tube |  Capsule Administration |  Chronic Diarrhea |  Inflammatory Bowel Disease (IBD) | Irritable Bowel Syndrome (IBS) |  Metabolic Syndrome |  Immune Modulation |  Safety and Efficacy | Clinical Trial.</font></p><p class="MsoNormal" style="text-align: justify;"><b><font color="#000000"><br></font></b></p><p class="MsoNormal" style="text-align: justify;"><font color="#000000"><b>Session 11: Systemic Diseases and GI Manifestations</b>-<b>Systemic diseases,</b> such as diabetes, lupus, and systemic sclerosis, often present gastrointestinal (GI) manifestations like gastroparesis, malabsorption, and dysmotility. These manifestations can significantly impact a patient's quality of life and complicate disease management. Early recognition and targeted treatments of GI symptoms are essential for comprehensive care.<o:p></o:p></font></p><p class="MsoNormal" style="text-align: justify;"><font color="#000000">Systemic Lupus Erythematosus (SLE) |  Rheumatoid Arthritis |  Diabetes Mellitus |  Celiac Disease |  Crohn's Disease | Ulcerative Colitis |  Scleroderma |  Primary Biliary Cholangitis |  Autoimmune Hepatitis |  Thyroid Disorders |  Vasculitis |  Hyper Lipidemia |  Amyloidosis  |  Sarcoidosis  |  Hemochromatosis |  HIV/AIDS | Systemic Infections |  Chronic Kidney Disease |  Peptic Ulcer Disease |  Gastrointestinal Bleeding.</font></p><p class="MsoNormal" style="text-align: justify;"><b><font color="#000000"><br></font></b></p><p class="MsoNormal" style="text-align: justify;"><font color="#000000"><b>Session 12: Gut Permeability</b>: <b>Gut permeability,</b> also known as "leaky gut," is the term used to describe the condition in which the intestinal lining becomes more porous, allowing poisons and bigger molecules to enter the circulation. Diet, stress, illnesses, and some medications can all have an impact on this condition. There are several health problems associated with increased intestinal permeability, such as inflammatory and autoimmune illnesses.</font></p><p class="MsoNormal" style="text-align:justify"><font color="#000000">Leaky Gut Syndrome | Tight Junctions | Zonulin | Intestinal Barrier Function | Endotoxemia | Lipopolysaccharides (LPS) | Microbial Translocation | Inflammatory Cytokines | Gut Microbiota | Probiotic | Prebiotics | Intestinal Inflammation | Chronic Disease | Autoimmune Disorders | Celiac Disease | Irritable Bowel Syndrome (IBS) | Inflammatory Bowel Disease (IBD) | Dietary Factors | Oxidative Stress | Intestinal Permeability Testing.<o:p></o:p></font></p><p class="MsoNormal" style="text-align: justify;"><b><font color="#000000"><br></font></b></p><p class="MsoNormal" style="text-align: justify;"><font color="#000000"><b>Session 13: Advances in GI Surgery: </b>Advances in gastrointestinal (GI) surgery include minimally invasive techniques like laparoscopic and robotic-assisted surgeries, which reduce recovery times and complications. Enhanced imaging and precision tools improve surgical accuracy and outcomes. Innovations in tissue engineering and regenerative medicine offer potential for repairing or replacing damaged GI tissues. Personalized approaches, leveraging patient-specific data, are improving the efficacy and safety of GI surgical interventions.</font></p><p class="MsoNormal" style="text-align:justify"><font color="#000000">Minimally Invasive Surgery | Laparoscopic Surgery | Robotic-Assisted Surgery | Endoscopic Techniques | Single-Incision Laparoscopic Surgery (SILS) | Natural Orifice Transluminal Endoscopic Surgery (NOTES) | Enhanced Recovery After Surgery (ERAS) | Surgical Navigation | 3D Imaging | Virtual Reality in Surgery | Augmented Reality | Preoperative Planning | Patient-Specific Implants | Complex Hernia Repair | Transanal Minimally Invasive Surgery (TAMIS) | Sphincter-Preserving Surgery | Bioelectronic Medicine | Telemedicine in Surgery | Scarless Surgery | Robotic Liver Resection.<o:p></o:p></font></p><p class="MsoNormal" style="text-align: justify;"><b><font color="#000000"><br></font></b></p><p class="MsoNormal" style="text-align: justify;"><font color="#000000"><b>Session 14: Esophageal Disorders:</b><span style="font-size: 12pt; line-height: 107%; font-family: "Times New Roman", serif;"> </span>Esophageal disorders, Chest pain, difficulty swallowing, and heartburn are common symptoms. Imaging, pH monitoring, and endoscopy are frequently used in diagnosis. Depending on the severity and underlying reason, treatment options range from medication and lifestyle modifications to surgical treatments.</font></p><p class="MsoNormal" style="text-align:justify"><font color="#000000">Gastroesophageal Reflux Disease (GERD) | Esophageal Cancer | Achalasia | Barrett's Esophagus | Esophagitis | Dysphagia | Esophageal Stricture | Hiatal Hernia | Esophageal Varices | Eosinophilic Esophagitis | Pill-Induced Esophagitis | Esophageal Motility Disorders | Endoscopic Mucosal Resection (EMR) | Peroral Endoscopic Myotomy (POEM) | Barium Swallow | Esophageal Manometry | Fundoplication | Sclerotherapy | Photodynamic Therapy | Cryotherapy.<o:p></o:p></font></p><p class="MsoNormal" style="text-align: justify;"><b><font color="#000000"><br></font></b></p><p class="MsoNormal" style="text-align: justify;"><font color="#000000"><b>Session 15: Environmental Impact</b>: Environmental impact of human activities includes pollution, deforestation, and climate change, leading to loss of biodiversity and ecosystem damage. Industrial processes and fossil fuel consumption release greenhouse gases, driving global warming. Sustainable practices and renewable energy adoption are essential for mitigating these impacts and protecting the planet.</font></p><p class="MsoNormal" style="text-align:justify"><font color="#000000">Climate Change | Carbon Footprint | Greenhouse Gases | Sustainability | Biodiversity Loss | Deforestation | Pollution | Ecosystem Degradation | Renewable Energy | Waste Management | Recycling | Environmental Conservation | Resource Depletion | Soil Erosion | Ocean Acidification | Global Warming | Ecological Footprint | Habitat Destruction | Carbon Offsetting | Environmental Regulations.<o:p></o:p></font></p><p class="MsoNormal" style="text-align: justify;"><b><font color="#000000"><br></font></b></p><p class="MsoNormal" style="text-align: justify;"><font color="#000000"><b>Session 16: Biomarkers-</b><span style="font-size: 12pt; line-height: 107%; font-family: "Times New Roman", serif;"> </span><b>Biomarkers </b>are quantifiable markers of biological processes, disorders, or illnesses that are utilised in therapy response monitoring, diagnosis, and prognosis. These could be chemicals present in blood, tissues, or other body fluids, such as proteins, DNA, or metabolites. Personalised medicine relies heavily on biomarkers to enable customised therapies based on patient profiles. The goal of ongoing research is to find new biomarkers for a variety of diseases, improving treatment approaches and early detection.</font></p><p class="MsoNormal" style="text-align:justify"><font color="#000000">Diagnostic Biomarkers | Prognostic Biomarkers | Predictive Biomarkers | Biomarker Panels | Genetic Biomarkers | Protein Biomarkers | Metabolic Biomarkers | Epigenetic Biomarkers | Biomarker Validation | Biomarker Discovery | Clinical Biomarkers | Surrogate Endpoints | Pharmacodynamic Biomarkers | Biomarker Assays | Biomarker Quantification | Tissue Biomarkers | Serological Biomarkers | Tumor Markers | Inflammatory Biomarkers | Pharmacogenomic Biomarkers.<o:p></o:p></font></p><p class="MsoNormal" style="text-align: justify;"><font color="#000000"><b>Session 17: Pharmacological Advances</b>-<span style="font-size: 12pt; line-height: 107%; font-family: "Times New Roman", serif;"> </span><b>Pharmacological advancements</b> has greatly improved the results of treatment for a number of ailments. Precision medicine techniques are among the innovations; these involve customising therapies according to molecular and genetic profiles. New developments in drug delivery, like sustained-release formulations and nanoparticles, improve efficacy while lowering side effects.</font></p><p class="MsoNormal" style="text-align:justify"><font color="#000000">Targeted Therapy | Precision Medicine | Biologics | Immunotherapy | Nanomedicine | Gene Therapy | Pharmacogenomics | Drug Delivery Systems | Small Molecule Drugs | Monoclonal Antibodies | Checkpoint Inhibitors | CAR-T Cell Therapy | Bioinformatics | Pharmacokinetics | Pharmacodynamics | New Chemical Entities (NCEs) | Pharmacovigilance | Drug Repurposing | Pharmacoeconomics | Orphan Drugs.<o:p></o:p></font></p><p class="MsoNormal" style="text-align: justify;"><b><font color="#000000"><br></font></b></p><p class="MsoNormal" style="text-align: justify;"><font color="#000000"><b>Session 18: Patient-Centered Care</b>-<span style="font-size: 12pt; line-height: 107%; font-family: "Times New Roman", serif;"> </span><b>Patient-centered care</b> gives individuals' unique needs, preferences, and values first priority throughout the medical procedure. It entails cooperative decision-making between patients and healthcare professionals, effective communication, and active patient participation. This method creates a more caring hospital atmosphere, increases patient happiness, and improves health outcomes.</font></p><p class="MsoNormal" style="text-align:justify"><font color="#000000">Shared Decision-Making | Patient Engagement | Holistic Care | Personalized Care | Care Coordination | Patient Advocacy | Informed Consent | Patient Experience | Communication Skills | Empathy | Cultural Competence | Patient Preferences | Care Planning | Continuity of Care | Patient Empowerment | Family Involvement | Access to Information | Respect for Autonomy | Health Literacy | Patient Feedback.<o:p></o:p></font></p><p class="MsoNormal" style="text-align: justify;"><b><font color="#000000"><br></font></b></p><p class="MsoNormal" style="text-align: justify;"><font color="#000000"><b>Session 19: Inflammatory Bowel Disease (IBD)-Inflammatory Bowel Disease (IBD)</b> encompasses chronic conditions like Crohn's disease and ulcerative colitis, characterized by inflammation of the digestive tract. The exact cause is unknown, but it involves immune system dysfunction, genetics, and environmental factors.</font></p><p class="MsoNormal" style="text-align:justify"><font color="#000000">Crohn's Disease | Ulcerative Colitis | Intestinal Inflammation | Biologic Therapies | Immunosuppressants | Disease Remission | Fistulas | Colonoscopy | Endoscopy | Strictures | Flare-Ups | Probiotics | Anti-TNF Agents | Corticosteroids | Nutritional Management | Microscopic Colitis | Surgical Resection | Inflammatory Markers | Genetic Predisposition | Biomarkers.</font><o:p></o:p></p> <p></p> </div> <div id="market" class="tabcontent text-justify"> <p class="MsoNormal" style="text-align: center;"><b><font color="#000000">Market Analysis of Gastrointestinal Research and Therapy<o:p></o:p></font></b></p><p class="MsoNormal" style="text-align: justify;"><o:p><font color="#000000"> </font></o:p><span style="color: rgb(0, 0, 0); text-align: justify;">The gastrointestinal (GI) research and therapy sector has seen substantial growth over the past decade, driven by advancements in medical research, the increasing prevalence of gastrointestinal diseases, and a heightened focus on preventive medicine. With a growing global burden of conditions such as inflammatory bowel disease (IBD), gastroesophageal reflux disease (GERD), colorectal cancer, and liver diseases, the demand for innovative therapies, improved diagnostics, and preventive strategies is higher than ever.</span></p><p class="MsoNormal" style="text-align: center;"><b><font color="#000000">Research and Innovations in Gastrointestinal Therapy<o:p></o:p></font></b></p><p class="MsoNormal" style="text-align:justify"><font color="#000000">Research in gastrointestinal diseases is expanding rapidly, focusing on key areas such as the gut microbiome, genetic predispositions, and inflammatory pathways that contribute to GI disorders. These research initiatives are driven by the need for more effective, less invasive treatments that address the root causes of diseases rather than just their symptoms. <o:p></o:p></font></p><p class="MsoNormal" style="text-align:justify"><font color="#000000">Breakthroughs in research—such as gene therapies, immunomodulatory treatments, and biologics—have revolutionized the management of Crohn’s disease, ulcerative colitis, and gastrointestinal cancers. In addition, probiotics and prebiotics have become increasingly important in maintaining gut health and preventing disorders like irritable bowel syndrome (IBS)and colitis. <o:p></o:p></font></p><p class="MsoNormal" style="text-align: center;"><b><font color="#000000">Benefits of Innovations in Gastrointestinal Research<o:p></o:p></font></b></p><p class="MsoNormal" style="text-align:justify"><font color="#000000">Innovations in gastrointestinal research have led to significant improvements in disease management. These include:<o:p></o:p></font></p><p class="MsoNormal" style="text-align:justify"><font color="#000000">Early detection: The development of biomarkers and genetic screening tools allows for earlier diagnosis, especially in colorectal cancer and liver diseases. Early detection improves survival rates and reduces the overall healthcare burden.<o:p></o:p></font></p><p class="MsoNormal" style="text-align:justify"><font color="#000000">Targeted therapies: Precision medicine and targeted therapies—including biologics like anti-TNF agents and checkpoint inhibitors—have provided new avenues for treating complex GI diseases, improving remission rates, and reducing flare-ups in IBD and Crohn’s disease.<o:p></o:p></font></p><p class="MsoNormal" style="text-align:justify"><font color="#000000">Minimally invasive treatments: Advances in endoscopic techniques and robotic surgeries have made procedures less invasive, reducing recovery times and improving patient outcomes for conditions like GI cancers and obstructions.<o:p></o:p></font></p><p class="MsoNormal" style="text-align:justify"><font color="#000000">Preventive strategies: Preventive medicines and therapies, such as the use of probiotics, dietary interventions, and fecal microbiota transplantation (FMT), have shown promise in controlling GI diseases and restoring a healthy gut environment. These strategies help reduce the risk of developing chronic conditions and have been particularly beneficial in managing dysbiosis and inflammatory disorders.<o:p></o:p></font></p><p class="MsoNormal" style="text-align: center;"><b><font color="#000000"> Funds Allocation in Gastrointestinal Research<o:p></o:p></font></b></p><p class="MsoNormal" style="text-align:justify"><font color="#000000">The allocation of research funding in the gastrointestinal sector has steadily increased, with significant contributions from government health agencies, private organizations, and pharmaceutical companies. In the U.S., the National Institutes of Health (NIH)allocates billions of dollars annually to gastrointestinal research, targeting areas such as liver diseases, IBD, and GI cancers. Similarly, Europe and Asia have seen increased funding from national health bodies and private investors, aiming to address the rising incidence of GI disorders.</font><span style="color: rgb(0, 0, 0);"> </span></p><p class="MsoNormal" style="text-align:justify"><font color="#000000">Private funding has also surged, with biotech companies and pharmaceutical giants investing in the development of biologics, new chemical entities (NCEs), and clinical trials for innovative treatments. Pharmaceutical companies have focused on developing small-molecule drugs and monoclonal antibodies targeting specific pathways involved in GI inflammation and tumor growth.<o:p></o:p></font></p><p class="MsoNormal" style="text-align: center;"><b><font color="#000000">Innovations and Their Role in Controlling Gastrointestinal Diseases<o:p></o:p></font></b></p><p class="MsoNormal" style="text-align:justify"><font color="#000000">Innovative therapies are at the forefront of controlling and managing gastrointestinal diseases. Advances in personalized medicine, pharmacogenomics, and nanomedicine have enabled more effective and tailored treatments, improving outcomes for patients with chronic GI conditions. For example:<o:p></o:p></font></p><p class="MsoNormal" style="text-align:justify"><font color="#000000">Biologic therapies such as anti-TNF agents and IL-23 inhibitors have become crucial in managing severe cases of IBD, significantly reducing hospitalizations and surgeries.<o:p></o:p></font></p><p class="MsoNormal" style="text-align:justify"><font color="#000000">Nanomedicine has enabled more precise drug delivery, ensuring that medications target the affected areas in the GI tract without damaging surrounding tissues.<o:p></o:p></font></p><p class="MsoNormal" style="text-align:justify"><font color="#000000">Gene therapy is being explored for its potential to correct genetic mutations that lead to chronic GI diseases, offering long-term solutions and potentially curing previously untreatable conditions.<o:p></o:p></font></p><p class="MsoNormal" style="text-align: center;"><b><font color="#000000">Preventive Medicine and Controlling Methods<o:p></o:p></font></b></p><p class="MsoNormal" style="text-align:justify"><font color="#000000">The increasing focus on preventive medicine has led to the development of strategies aimed at maintaining a healthy gut and reducing the risk of developing GI disorders. Dietary changes, lifestyle modifications, and early screening are key components of this preventive approach. <o:p></o:p></font></p><p class="MsoNormal" style="text-align:justify"><font color="#000000">Gut microbiome research has highlighted the importance of probiotic sand prebiotics in maintaining gut health and preventing diseases like IBS, colitis, and GERD. This has led to an increase in functional foods and nutritional supplements tailored to improve gut health.<o:p></o:p></font></p><p class="MsoNormal" style="text-align:justify"><font color="#000000">Fecal microbiota transplantation (FMT)is another innovative preventive and therapeutic method that has been successful in treating conditions like Clostridium difficile infection and holds potential for treating IBD and IBS.<o:p></o:p></font></p><p class="MsoNormal" style="text-align:justify"><font color="#000000">Controlling methods such as minimally invasive surgeries, endoscopic interventions, and non-surgical treatments have improved the management of GI diseases, particularly in cases of cancer and obstructions. The integration of robotic-assisted surgeries and advanced imaging techniques has enhanced precision and patient recovery.</font></p><p class="MsoNormal" style="text-align: center;"><b><font color="#000000">Research Levels and Ongoing Studies<o:p></o:p></font></b></p><p class="MsoNormal" style="text-align:justify"><font color="#000000">Ongoing research in the gastrointestinal field is being conducted at various levels:<o:p></o:p></font></p><p class="MsoNormal" style="text-align:justify"><font color="#000000">Basic research focuses on understanding the mechanisms of disease, including microbiome composition, inflammatory pathways, and genetic mutations associated with GI conditions.<o:p></o:p></font></p><p class="MsoNormal" style="text-align:justify"><font color="#000000">Translational research bridges the gap between basic science and clinical application, developing new therapies, biomarkers, and drug delivery systems for practical use in treating GI diseases.</font><span style="color: rgb(0, 0, 0);"> </span></p><p class="MsoNormal" style="text-align:justify"><font color="#000000">Clinical research is vital in testing the safety and efficacy of new therapies in real-world settings. Phase I–III clinical trials are ongoing for biologics, gene therapies, and nano medicine to address the unmet needs in GI health.<o:p></o:p></font></p><p class="MsoNormal" style="text-align:justify"><b><font color="#000000">Conclusion<o:p></o:p></font></b></p><p class="MsoNoSpacing" style="text-align: justify; "> </p><p class="MsoNormal" style="text-align:justify"><font color="#000000">The market for gastrointestinal research and therapy is expected to grow significantly, driven by the rising prevalence of GI diseases, continued investment in research and development, and the emergence of innovative therapies. Targeted treatments, preventive strategies, and cutting-edge biological therapies are reshaping how gastrointestinal diseases are managed, offering hope for improved outcomes and better quality of life for millions of patients worldwide. Continued research and funding will further push the boundaries of treatment possibilities, helping to control and even prevent many gastrointestinal disorders in the future.</font><o:p></o:p></p> </div> <div id="take_away" class="tabcontent text-justify"> <p class="MsoNormal" style="text-align: justify; line-height: normal;"><b>Takeaway</b></p> <p class="MsoNormal" style="text-align: justify; line-height: normal; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">Participants can expect to gain valuable insights into the latest research findings, technological advancements, and policy developments shaping the future of environmental science. The congress offers a platform for knowledge exchange, collaboration opportunities, and professional growth.</p> <p class="MsoNormal" style="text-align: justify; line-height: normal; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;"><b><br></b></p><p class="MsoNormal" style="text-align: justify; line-height: normal; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;"><b>Networking for future collaborations:  <o:p></o:p></b></p> <p class="MsoNormal" style="text-align: justify; line-height: normal; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">Best opportunity for all attendees will have access to connect with fellow scholars and professors, to exchange insights on the latest developments. Our primary goal is to enhance research collaboration throughout the conference which nurtures a cooperative learning environment. It simplifies the sharing of innovative ideas and practices but also paves the way for future collaborative projects and partnerships. Attendees can expect to leave with expanded networks, enriched knowledge, and potential pathways for academic and professional growth. The Gastrointestinal Research Conference 2024 promotes connections that exceed geographical and disciplinary boundaries, encouraging a dynamic exchange of knowledge that could lead to revolutionary advancements in their respective fields.</p><p class="MsoNormal" style="text-align: justify; line-height: normal; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;"><b><br></b></p><p class="MsoNormal" style="text-align: justify; line-height: normal; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;"><b>Enhanced Research Impact:</b> Our organization offers an exceptional platform for attendees from relevant fields and designed sessions that significantly enrich your career with profound research insights. This scientific event is organized by our organizing committee members to facilitate unrestricted access to diverse research activities within your field, encompassing current trends and emerging challenges. Additionally, our event is recognized for awarding CPD credits (Continuing Professional Development), active in supporting the ongoing advancement and enhancement of your expertise.</p> <p class="MsoNormal" style="text-align: justify;"><span style="line-height: 107%;"> </span></p> </div> <div class="row"> <div class="col-md-12"> <section id="brand" class="brand speakers scientific-committee" style="padding: 46px 0;"> <div class="about-us" style="padding: 0; background-color:unset"> <h1>Scientific Committee Members</h1> </div> <div class="brand-area" style="margin-top: 30px; padding-bottom:0"> <div class="owl-carousel owl-theme brand-item3"> </div> </div> </section> </div> </div> <section id="brand" class="speakers"> <div class="about-us" style="padding: 0; background-color:unset"> <h1>Speakers</h1> </div> <div class="brand-area" style="margin-top: 35px;"> <div class="owl-carousel owl-theme brand-item2"> </div> </div> </section> <section id="brand" class="speakers" > <div class="about-us" style="padding: 0; background-color:unset;margin-top: 40px;"> <h1>Gallery</h1> </div> <div class="brand-area" style="margin-top: 34px;"> <div class="owl-carousel owl-theme brand-item2"> </div> </div> </section> </div> <div class="col-md-4"> <div class="card mb-4" > <div class="card-body p-4"> <div class="d-grid gap-2"> <a href="https://opulentconferences.com/registration/gastro-2025" style="text-decoration: none"> <h5 class="event-button" style="margin-bottom: 0px;">Register Now</h5> </a> </div> </div> </div> <div class="card mb-4" style="margin-top:25px" > <div class="card-body p-4"> <div class="d-grid gap-2"> <a href="#" style="text-decoration: none"> <h5 class="event-button" style="margin-bottom: 0px;">Get Brochure</h5> </a> </div> </div> </div> <div class="card mb-4" style="margin-top: 25px;"> <div class="card-body p-4"> <div class="d-grid gap-2" style="margin-bottom: 15px;"> <h5 class="event-button">Venue</h5> </div> <ul> <li><a href="https://opulentconferences.com/venue/vienna">Vienna</a></li> </ul> </div> </div> <div class="card mb-4" style="margin-top: 25px;"> <div class="card-body p-4"> <div class="d-grid gap-2" style="margin-bottom: 15px;"> <h5 class="event-button">Date</h5> </div> <p> 29 Apr 2025 (UTC) - 30 Apr 2025 (UTC) </p> </div> </div> <div class="card mb-4" style="margin-top: 25px;"> <div class="card-body"> <div class="d-grid gap-2" style="margin-bottom: 15px;"> <h5 class="event-button">Recent Posts</h5> </div> <div class="social-media-posting"> <div class="card-container"> <a href="https://opulentconferences.com/blogs/surgeons-congress" class="hero-image-container"> <img class="hero-image" src="https://opulentconferences.com/public//Blog/6896550-1721705642.jpeg" alt="Spinning glass cube"/> </a> <main class="main-content"> <div class="card-attribute">  <h1><a href="https://opulentconferences.com/blogs/surgeons-congress">Surgeons Congress</a></h1> </div>  <div class="flex-row"> <div class="time-left"> <img src="https://i.postimg.cc/prpyV4mH/clock-selection-no-bg.png" alt="clock" class="small-image"/> <p>5 months ago</p> </div> </div> </main> </div> <div class="card-container"> <a href="https://opulentconferences.com/blogs/welcome-to-a-unique-and-engaging-conference" class="hero-image-container"> <img class="hero-image" src="https://opulentconferences.com/public//Blog/9388447-1721705713.jpeg" alt="Spinning glass cube"/> </a> <main class="main-content"> <div class="card-attribute">  <h1><a href="https://opulentconferences.com/blogs/welcome-to-a-unique-and-engaging-conference">Welcome to a unique and engaging conference</a></h1> </div>  <div class="flex-row"> <div class="time-left"> <img src="https://i.postimg.cc/prpyV4mH/clock-selection-no-bg.png" alt="clock" class="small-image"/> <p>5 months ago</p> </div> </div> </main> </div> <div class="card-container"> <a href="https://opulentconferences.com/blogs/the-thriving-vaccine-and-immunology-market" class="hero-image-container"> <img class="hero-image" src="https://opulentconferences.com/public//Blog/8410346-1721705666.jpeg" alt="Spinning glass cube"/> </a> <main class="main-content"> <div class="card-attribute">  <h1><a href="https://opulentconferences.com/blogs/the-thriving-vaccine-and-immunology-market">The Thriving Vaccine and Immunology Market</a></h1> </div>  <div class="flex-row"> <div class="time-left"> <img src="https://i.postimg.cc/prpyV4mH/clock-selection-no-bg.png" alt="clock" class="small-image"/> <p>5 months ago</p> </div> </div> </main> </div> <div class="card-container"> <a href="https://opulentconferences.com/blogs/shaping-the-future-of-pediatric-and-neonatal-care" class="hero-image-container"> <img class="hero-image" src="https://opulentconferences.com/public//Blog/6910399-1721705607.jpeg" alt="Spinning glass cube"/> </a> <main class="main-content"> <div class="card-attribute">  <h1><a href="https://opulentconferences.com/blogs/shaping-the-future-of-pediatric-and-neonatal-care">Shaping the Future of Pediatric and Neonatal Care</a></h1> </div>  <div class="flex-row"> <div class="time-left"> <img src="https://i.postimg.cc/prpyV4mH/clock-selection-no-bg.png" alt="clock" class="small-image"/> <p>5 months ago</p> </div> </div> </main> </div>                      </div> </div> </div> <div class="card mb-4" style="margin-top: 25px;"> <div class="card-body"> <div class="d-grid gap-2" style="margin-bottom: 15px;"> <h5 class="event-button">Supporting Journals</h5> </div> <div class="card-container"> <a href="" class="hero-image-container"> <img class="hero-image" src="https://opulentconferences.com/public" alt="Spinning glass cube"/> </a> </div> </div> </div> <div class="card mb-4" style="margin-top: 25px;"> <div class="card-body p-4"> <div class="d-grid gap-2" style="margin-bottom: 15px;"> <h5 class="event-button">Subscribe</h5> </div> <form id="signup-form" action="https://opulentconferences.com/events/subscrsibe" method="POST"> <input type="hidden" name="_token" value="ttnFuIT27vkacgFLOcAFnR8RUQobarb5xVXwBIAQ"> <div class="row"> <div class="col-md-12"> <div class="form-outline mb-2 event-form"> <label for="form2Example1" class="form-label">Name</label> <input type="text" name="name" id="form2Example1" placeholder="Your name" class="form-control"> </div> </div> <div class="col-md-12"> <div class="form-outline mb-3 event-form"> <label for="form2Example2" class="form-label">Email</label> <input type="text" name="email" id="form2Example2" placeholder="Your Email" class="form-control"> </div> </div> <div class="col-md-12"> <div class="form-outline mb-3 event-form"> <label for="form2Example2" class="form-label">Phone Number</label> <input type="text" name="phone" id="form2Example2" placeholder="Phone Number" class="form-control"> </div> </div> <div class="col-md-12"> <div class="form-outline mb-2 event-form"> <label for="countrySelect" class="form-label">Country</label> <div class="select-wrapper"> <select id="countrySelect" name="country" aria-label="Default select example" class="form-select form-control"> <option value="">Select Country</option> <option value="Afghanistan">Afghanistan</option> <option value="Aland Islands">Aland Islands</option> <option value="Albania">Albania</option> <option value="Algeria">Algeria</option> <option value="American Samoa">American Samoa</option> <option value="Andorra">Andorra</option> <option value="Angola">Angola</option> <option value="Anguilla">Anguilla</option> <option value="Antarctica">Antarctica</option> <option value="Antigua and Barbuda">Antigua and Barbuda</option> <option value="Argentina">Argentina</option> <option value="Armenia">Armenia</option> <option value="Aruba">Aruba</option> <option value="Australia">Australia</option> <option value="Austria">Austria</option> <option value="Azerbaijan">Azerbaijan</option> <option value="Bahamas">Bahamas</option> <option value="Bahrain">Bahrain</option> <option value="Bangladesh">Bangladesh</option> <option value="Barbados">Barbados</option> <option value="Belarus">Belarus</option> <option value="Belgium">Belgium</option> <option value="Belize">Belize</option> <option value="Benin">Benin</option> <option value="Bermuda">Bermuda</option> <option value="Bhutan">Bhutan</option> <option value="Bolivia">Bolivia</option> <option value="Bonaire, Sint Eustatius and Saba">Bonaire, Sint Eustatius and Saba</option> <option value="Bosnia and Herzegovina">Bosnia and Herzegovina</option> <option value="Botswana">Botswana</option> <option value="Bouvet Island">Bouvet Island</option> <option value="Brazil">Brazil</option> <option value="British Indian Ocean Territory">British Indian Ocean Territory</option> <option value="Brunei">Brunei</option> <option value="Bulgaria">Bulgaria</option> <option value="Burkina Faso">Burkina Faso</option> <option value="Burundi">Burundi</option> <option value="Cambodia">Cambodia</option> <option value="Cameroon">Cameroon</option> <option value="Canada">Canada</option> <option value="Cape Verde">Cape Verde</option> <option value="Cayman Islands">Cayman Islands</option> <option value="Central African Republic">Central African Republic</option> <option value="Chad">Chad</option> <option value="Chile">Chile</option> <option value="China">China</option> <option value="Christmas Island">Christmas Island</option> <option value="Cocos (Keeling) Islands">Cocos (Keeling) Islands</option> <option value="Colombia">Colombia</option> <option value="Comoros">Comoros</option> <option value="Congo">Congo</option> <option value="Cook Islands">Cook Islands</option> <option value="Costa Rica">Costa Rica</option> <option value="Ivory Coast">Ivory Coast</option> <option value="Croatia">Croatia</option> <option value="Cuba">Cuba</option> <option value="Curacao">Curacao</option> <option value="Cyprus">Cyprus</option> <option value="Czech Republic">Czech Republic</option> <option value="Democratic Republic of the Congo">Democratic Republic of the Congo</option> <option value="Denmark">Denmark</option> <option value="Djibouti">Djibouti</option> <option value="Dominica">Dominica</option> <option value="Dominican Republic">Dominican Republic</option> <option value="Ecuador">Ecuador</option> <option value="Egypt">Egypt</option> <option value="El Salvador">El Salvador</option> <option value="Equatorial Guinea">Equatorial Guinea</option> <option value="Eritrea">Eritrea</option> <option value="Estonia">Estonia</option> <option value="Ethiopia">Ethiopia</option> <option value="Falkland Islands (Malvinas)">Falkland Islands (Malvinas)</option> <option value="Faroe Islands">Faroe Islands</option> <option value="Fiji">Fiji</option> <option value="Finland">Finland</option> <option value="France">France</option> <option value="French Guiana">French Guiana</option> <option value="French Polynesia">French Polynesia</option> <option value="French Southern Territories">French Southern Territories</option> <option value="Gabon">Gabon</option> <option value="Gambia">Gambia</option> <option value="Georgia">Georgia</option> <option value="Germany">Germany</option> <option value="Ghana">Ghana</option> <option value="Gibraltar">Gibraltar</option> <option value="Greece">Greece</option> <option value="Greenland">Greenland</option> <option value="Grenada">Grenada</option> <option value="Guadaloupe">Guadaloupe</option> <option value="Guam">Guam</option> <option value="Guatemala">Guatemala</option> <option value="Guernsey">Guernsey</option> <option value="Guinea">Guinea</option> <option value="Guinea-Bissau">Guinea-Bissau</option> <option value="Guyana">Guyana</option> <option value="Haiti">Haiti</option> <option value="Heard Island and McDonald Islands">Heard Island and McDonald Islands</option> <option value="Honduras">Honduras</option> <option value="Hong Kong">Hong Kong</option> <option value="Hungary">Hungary</option> <option value="Iceland">Iceland</option> <option value="India">India</option> <option value="Indonesia">Indonesia</option> <option value="Iran">Iran</option> <option value="Iraq">Iraq</option> <option value="Ireland">Ireland</option> <option value="Isle of Man">Isle of Man</option> <option value="Israel">Israel</option> <option value="Italy">Italy</option> <option value="Jamaica">Jamaica</option> <option value="Japan">Japan</option> <option value="Jersey">Jersey</option> <option value="Jordan">Jordan</option> <option value="Kazakhstan">Kazakhstan</option> <option value="Kenya">Kenya</option> <option value="Kiribati">Kiribati</option> <option value="Kosovo">Kosovo</option> <option value="Kuwait">Kuwait</option> <option value="Kyrgyzstan">Kyrgyzstan</option> <option value="Laos">Laos</option> <option value="Latvia">Latvia</option> <option value="Lebanon">Lebanon</option> <option value="Lesotho">Lesotho</option> <option value="Liberia">Liberia</option> <option value="Libya">Libya</option> <option value="Liechtenstein">Liechtenstein</option> <option value="Lithuania">Lithuania</option> <option value="Luxembourg">Luxembourg</option> <option value="Macao">Macao</option> <option value="Macedonia">Macedonia</option> <option value="Madagascar">Madagascar</option> <option value="Malawi">Malawi</option> <option value="Malaysia">Malaysia</option> <option value="Maldives">Maldives</option> <option value="Mali">Mali</option> <option value="Malta">Malta</option> <option value="Marshall Islands">Marshall Islands</option> <option value="Martinique">Martinique</option> <option value="Mauritania">Mauritania</option> <option value="Mauritius">Mauritius</option> <option value="Mayotte">Mayotte</option> <option value="Mexico">Mexico</option> <option value="Micronesia">Micronesia</option> <option value="Moldava">Moldava</option> <option value="Monaco">Monaco</option> <option value="Mongolia">Mongolia</option> <option value="Montenegro">Montenegro</option> <option value="Montserrat">Montserrat</option> <option value="Morocco">Morocco</option> <option value="Mozambique">Mozambique</option> <option value="Myanmar (Burma)">Myanmar (Burma)</option> <option value="Namibia">Namibia</option> <option value="Nauru">Nauru</option> <option value="Nepal">Nepal</option> <option value="Netherlands">Netherlands</option> <option value="New Caledonia">New Caledonia</option> <option value="New Zealand">New Zealand</option> <option value="Nicaragua">Nicaragua</option> <option value="Niger">Niger</option> <option value="Nigeria">Nigeria</option> <option value="Niue">Niue</option> <option value="Norfolk Island">Norfolk Island</option> <option value="North Korea">North Korea</option> <option value="Northern Mariana Islands">Northern Mariana Islands</option> <option value="Norway">Norway</option> <option value="Oman">Oman</option> <option value="Pakistan">Pakistan</option> <option value="Palau">Palau</option> <option value="Palestine">Palestine</option> <option value="Panama">Panama</option> <option value="Papua New Guinea">Papua New Guinea</option> <option value="Paraguay">Paraguay</option> <option value="Peru">Peru</option> <option value="Phillipines">Phillipines</option> <option value="Pitcairn">Pitcairn</option> <option value="Poland">Poland</option> <option value="Portugal">Portugal</option> <option value="Puerto Rico">Puerto Rico</option> <option value="Qatar">Qatar</option> <option value="Reunion">Reunion</option> <option value="Romania">Romania</option> <option value="Russia">Russia</option> <option value="Rwanda">Rwanda</option> <option value="Saint Barthelemy">Saint Barthelemy</option> <option value="Saint Helena">Saint Helena</option> <option value="Saint Kitts and Nevis">Saint Kitts and Nevis</option> <option value="Saint Lucia">Saint Lucia</option> <option value="Saint Martin">Saint Martin</option> <option value="Saint Pierre and Miquelon">Saint Pierre and Miquelon</option> <option value="Saint Vincent and the Grenadines">Saint Vincent and the Grenadines</option> <option value="Samoa">Samoa</option> <option value="San Marino">San Marino</option> <option value="Sao Tome and Principe">Sao Tome and Principe</option> <option value="Saudi Arabia">Saudi Arabia</option> <option value="Senegal">Senegal</option> <option value="Serbia">Serbia</option> <option value="Seychelles">Seychelles</option> <option value="Sierra Leone">Sierra Leone</option> <option value="Singapore">Singapore</option> <option value="Sint Maarten">Sint Maarten</option> <option value="Slovakia">Slovakia</option> <option value="Slovenia">Slovenia</option> <option value="Solomon Islands">Solomon Islands</option> <option value="Somalia">Somalia</option> <option value="South Africa">South Africa</option> <option value="South Georgia and the South Sandwich Islands">South Georgia and the South Sandwich Islands</option> <option value="South Korea">South Korea</option> <option value="South Sudan">South Sudan</option> <option value="Spain">Spain</option> <option value="Sri Lanka">Sri Lanka</option> <option value="Sudan">Sudan</option> <option value="Suriname">Suriname</option> <option value="Svalbard and Jan Mayen">Svalbard and Jan Mayen</option> <option value="Swaziland">Swaziland</option> <option value="Sweden">Sweden</option> <option value="Switzerland">Switzerland</option> <option value="Syria">Syria</option> <option value="Taiwan">Taiwan</option> <option value="Tajikistan">Tajikistan</option> <option value="Tanzania">Tanzania</option> <option value="Thailand">Thailand</option> <option value="Timor-Leste (East Timor)">Timor-Leste (East Timor)</option> <option value="Togo">Togo</option> <option value="Tokelau">Tokelau</option> <option value="Tonga">Tonga</option> <option value="Trinidad and Tobago">Trinidad and Tobago</option> <option value="Tunisia">Tunisia</option> <option value="Turkey">Turkey</option> <option value="Turkmenistan">Turkmenistan</option> <option value="Turks and Caicos Islands">Turks and Caicos Islands</option> <option value="Tuvalu">Tuvalu</option> <option value="Uganda">Uganda</option> <option value="Ukraine">Ukraine</option> <option value="United Arab Emirates">United Arab Emirates</option> <option value="United Kingdom">United Kingdom</option> <option value="United States">United States</option> <option value="United States Minor Outlying Islands">United States Minor Outlying Islands</option> <option value="Uruguay">Uruguay</option> <option value="Uzbekistan">Uzbekistan</option> <option value="Vanuatu">Vanuatu</option> <option value="Vatican City">Vatican City</option> <option value="Venezuela">Venezuela</option> <option value="Vietnam">Vietnam</option> <option value="Virgin Islands, British">Virgin Islands, British</option> <option value="Virgin Islands, US">Virgin Islands, US</option> <option value="Wallis and Futuna">Wallis and Futuna</option> <option value="Western Sahara">Western Sahara</option> <option value="Yemen">Yemen</option> <option value="Zambia">Zambia</option> <option value="Zimbabwe">Zimbabwe</option> </select> </div> </div> </div> <div class="col-md-12"> <div class="form-outline mb-3 event-form"> <button id="submit-btn" class="btn btn-primary">Submit</button> </div> </div> </form> </div> </div> </div> </div> </section> <section style="padding: 70px 0px 0px"> <div class="row"> <div class="section-header"> <h2>Testimonials</h2> </div> <div class="row or-testimonial"> <div class="owl-carousel testimonial-carousell"> </div> </div> </div> </section> <section id="brand" class="brand" > <div class="container"> <div class="section-header"> <h2>Media Partners & Collaboration</h2> </div> <div class="brand-area"> <div class="owl-carousel owl-theme brand-item"> <div class="item"> <a href="#"> <img src="https://opulentconferences.com/public//media/1445318-1717233396.jpeg" alt="brand-image" /> </a> </div> <div class="item"> <a href="#"> <img src="https://opulentconferences.com/public//media/3421859-1717233406.jpeg" alt="brand-image" /> </a> </div> <div class="item"> <a href="#"> <img src="https://opulentconferences.com/public//media/2561596-1717233417.jpeg" alt="brand-image" /> </a> </div> <div class="item"> <a href="#"> <img src="https://opulentconferences.com/public//media/6231117-1717233426.jpeg" alt="brand-image" /> </a> </div> <div class="item"> <a href="#"> <img src="https://opulentconferences.com/public//media/3245791-1717233441.jpeg" alt="brand-image" /> </a> </div> <div class="item"> <a href="#"> <img src="https://opulentconferences.com/public//media/1470175-1717233454.jpeg" alt="brand-image" /> </a> </div> <div class="item"> <a href="#"> <img src="https://opulentconferences.com/public//media/1183313-1717233824.jpeg" alt="brand-image" /> </a> </div> <div class="item"> <a href="#"> <img src="https://opulentconferences.com/public//media/6599947-1717233833.jpeg" alt="brand-image" /> </a> </div> <div class="item"> <a href="#"> <img src="https://opulentconferences.com/public//media/7598674-1717660277.jpg" alt="brand-image" /> </a> </div> <div class="item"> <a href="#"> <img src="https://opulentconferences.com/public//media/6553547-1721628504.png" alt="brand-image" /> </a> </div> <div class="item"> <a href="#"> <img src="https://opulentconferences.com/public//media/1015629-1726741261.png" alt="brand-image" /> </a> </div> </div> </div> </div> </section>  <footer id="contact" class="contact"> <div class="container"> <div class="footer-top"> <div class="row"> <div class="col-md-3 col-sm-6"> <div class="single-footer-widget"> <div class="footer-logo"> <a href="/"> <img src="https://opulentconferences.com/public/front_assets/images/event/header-logo.png" class="footer-logo" width="200" height="50"> </a> </div> <p> 85 Great Portland Street, London, W1W 7LT, United Kingdom </p> <div class="footer-contact"> <p>info@opulentconferences.com</p> <p>+44 2045774235</p> </div> </div> </div> <div class="col-md-2 col-md-offset-1 col-sm-6"> <div class="single-footer-widget"> <h2>Useful Links</h2> <ul> <li><a href="https://opulentconferences.com/faqs">FAQs</a></li> <li><a href="https://opulentconferences.com/blogs">Blogs</a></li> <li><a href="https://opulentconferences.com/cancellation-and-refund-policy">Cancellation/Refund</a></li> <li><a href="https://opulentconferences.com/terms-and-conditions">Terms & Conditions</a></li> <li><a href="https://opulentconferences.com/privacy-policies">Privacy Policy</a></li> </ul> </div> </div> <div class="col-md-2 col-xs-12"> <div class="single-footer-widget"> <h2>Social Connections</h2> <ul> <li><a href="https://www.facebook.com/profile.php?id=61556079995952">Facebook</a></li> <li><a href="https://x.com/opulentconf">Twitter</a></li> <li><a href="https://opulentconferences.com/">Instagram</a></li> <li><a href="https://opulentconferences.com">Linkedin</a></li> </ul> </div> </div> <div class="col-md-offset-1 col-md-3 col-sm-6"> <div class="single-footer-widget"> <h2>news letter</h2> <div class="footer-newsletter"> <p> Subscribe to get latest news update and informations </p> </div> <div class="hm-foot-email"> <div class="foot-email-box"> <input type="text" class="form-control" placeholder="Add Email"> </div> <div class="foot-email-subscribe"> <span><i class="fa fa-arrow-right"></i></span> </div> </div> </div> </div> </div> </div> <div class="footer-copyright"> <div class="row"> <div class="col-sm-6"> <p> © 2024 <a href="#">Opulent Conferences </a> All Rights Reserved. </p> </div> <div class="col-sm-6"> <div class="footer-social"> <a href="https://www.facebook.com/profile.php?id=61556079995952"><i class="fab fa-facebook-f"></i></a> <a href="https://opulentconferences.com/"><i class="fab fa-instagram"></i></a> <a href="https://opulentconferences.com/"><i class="fab fa-linkedin"></i></a> <a href="https://x.com/opulentconf"><i class="fab fa-twitter"></i></a> </div> </div> </div> </div> </div>  </footer>   <script src="https://opulentconferences.com/public/front_assets/js/jquery.js"></script>  <script src="https://cdnjs.cloudflare.com/ajax/libs/modernizr/2.8.3/modernizr.min.js"></script>  <script src="https://opulentconferences.com/public/front_assets/js/bootstrap.min.js"></script>  <script src="https://opulentconferences.com/public/front_assets/js/bootsnav.js"></script>  <script src="https://opulentconferences.com/public/front_assets/js/owl.carousel.min.js"></script> <script src="https://cdnjs.cloudflare.com/ajax/libs/jquery-easing/1.4.1/jquery.easing.min.js"></script>  <script src="https://opulentconferences.com/public/front_assets/js/custom.js"></script> <script type="text/javascript"> var Tawk_API=Tawk_API||{}, Tawk_LoadStart=new Date(); (function(){ var s1=document.createElement("script"),s0=document.getElementsByTagName("script")[0]; s1.async=true; s1.src='https://embed.tawk.to/662bbe0fa0c6737bd130fea7/1hsddssbc'; s1.charset='UTF-8'; s1.setAttribute('crossorigin','*'); s0.parentNode.insertBefore(s1,s0); })(); </script> <script> document.addEventListener("DOMContentLoaded", function() { // Get all dropdown elements var dropdowns = document.querySelectorAll('.dropdown'); dropdowns.forEach(function(dropdown) { dropdown.addEventListener('touchstart', function(event) { // Prevent the click event from immediately following the touch event event.preventDefault(); // Toggle the dropdown menu visibility var dropdownMenu = this.querySelector('.dropdown-menu'); if (dropdownMenu.style.display === 'block') { dropdownMenu.style.display = 'none'; } else { dropdownMenu.style.display = 'block'; } }); }); // Close the dropdown menu when clicking outside of it document.addEventListener('click', function(event) { var isClickInside = dropdowns[0].contains(event.target); if (!isClickInside) { dropdowns.forEach(function(dropdown) { var dropdownMenu = dropdown.querySelector('.dropdown-menu'); dropdownMenu.style.display = 'none'; }); } }); }); </script> <script> function openCity(evt, cityName) { var i, tabcontent, tablinks; tabcontent = document.getElementsByClassName("tabcontent"); for (i = 0; i < tabcontent.length; i++) { tabcontent[i].style.display = "none"; } tablinks = document.getElementsByClassName("tablinks"); for (i = 0; i < tablinks.length; i++) { tablinks[i].className = tablinks[i].className.replace(" active", ""); } document.getElementById(cityName).style.display = "block"; evt.currentTarget.className += " active"; } $(document).ready(function() { // Trigger click event on the first tab to make it active by default $("#defaultOpen").click(); }); </script> </body> </html>

CINXE.COM

Opulent Conferences | Medical Events | Scientific Meetings | USA | Europe